Bioactive Efficacy of Novel Carboxylic Acid from Halophilic Pseudomonas aeruginosa against Methicillin-Resistant Staphylococcus aureus
Authors:
- Henciya SanthaseelanHSHenciya Santhaseelan
- Vengateshwaran Thasu DinakaranVengateshwaran Thasu Dinakaran
- Balasubramaniyan SakthivelBSBalasubramaniyan Sakthivel
- Maharaja SomasundaramMSMaharaja Somasundaram
- Kaviarasan ThanamegamKTKaviarasan Thanamegam
- Velmurugan DevendiranVDVelmurugan Devendiran
- Hans-Uwe DahmsHans-Uwe Dahms
- Arthur James RathinamARArthur James Rathinam
Open Access
- 10 November 2022
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 12 (11) , 1094
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasingly causing morbidity and mortality; thus, drugs with multifunctional efficacy against MRSA are needed. We extracted a novel compound from the halophilic Pseudomonas aeruginosa using an ethyl acetate (HPAEtOAcE). followed by purification and structure elucidation through HPLC, LCMS, and 1H and 13C NMR, revealing the novel 5-(1H-indol-3-yl)-4-pentyl-1,3-oxazole-2-carboxylic acid (Compound 1). Molecular docking of the compound against the MRSA PS (pantothenate synthetase) protein was confirmed using the CDOCKER algorithm in BDS software with specific binding to the amino acids Arg (B:188) and Lys (B:150) through covalent hydrogen bonding. Molecular dynamic simulation of RMSD revealed that the compound–protein complex was stabilized. The proficient bioactivities against MRSA were attained by the HPAEtOAcE, including MIC and MBCs, which were 0.64 and 1.24 µg/mL, respectively; 100% biomass inhibition and 99.84% biofilm inhibition were observed with decayed effects by CLSM and SEM at 48 h. The hla, IrgA, and SpA MRSA genes were downregulated in RT-PCR. Non-hemolytic and antioxidant potential in the DPPH assay were observed at 10 mg/mL and IC50 29.75 ± 0.38 by the HPAEtOAcE. In vitro growth inhibition assays on MRSA were strongly supported by in silico molecular docking; Lipinski’s rule on drug-likeness and ADMET toxicity prediction indicated the nontoxic nature of compound.Keywords
This publication has 88 references indexed in Scilit:
- Assessment of phytochemicals, antioxidant, anti-lipid peroxidation and anti-hemolytic activity of extract and various fractions of Maytenus royleanus leavesBMC Complementary and Alternative Medicine, 2013
- Attenuating Staphylococcus aureus Virulence Gene Regulation: A Medicinal Chemistry PerspectiveJournal of Medicinal Chemistry, 2013
- Novel Inhibitors of Staphylococcus aureus Virulence Gene Expression and Biofilm FormationPLOS ONE, 2012
- Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitorsBioorganic & Medicinal Chemistry Letters, 2012
- Antioxidant activity and free radical scavenging capacity of phenolic extracts from Helicteres isora L. and Ceiba pentandra L.Journal of Food Science and Technology, 2011
- Evaluation of toxic effects of several carboxylic acids on bacterial growth by toxicodynamic modellingMicrobial Cell Factories, 2011
- Damage of the Bacterial Cell Envelope by Antimicrobial Peptides Gramicidin S and PGLa as Revealed by Transmission and Scanning Electron MicroscopyAntimicrobial Agents and Chemotherapy, 2010
- Chapter 3. Carboxylic Acids and their Bioisosteres2010
- Bioactive substances produced by marine isolates of PseudomonasJournal of Industrial Microbiology and Biotechnology, 2009
- Endophytic fungi from plants living on gypsum soils as a source of secondary metabolites with antimicrobial activityMycological Research, 1998